Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the bioequivalence of 105 mg fenofibric acid tablets relative to 145
mg fenofibrate tablets in healthy volunteers when administered following a breakfast of
standard composition. Safety and tolerability of this regimen will also be evaluated.